Some Nvidia investors want Jensen Huang's return kept open, and the Treasury Secretary wants an outsider. Oil slipped as a third U.S. carrier arrived. Japan shrank. After bitcoin's weekend slide to $62,000, the $60,000 put is the biggest open bet.

MARKET PULSE

Nvidia's succession fight went public two days before its numbers.

Asia sold the chip trade first. Korea's Kospi fell about 3.6% and Taiwan's market more than 4%. Nasdaq 100 futures were down about 0.8% early Monday.

Nvidia (NVDA) traded more than 2% lower before the bell, near $158.50. Friday's $162.85 close capped six straight weekly losses, its longest streak since 2012.

Since Friday, the board has been pulled in two directions. Investors Brad Gerstner and Gavin Baker urged it not to rush and to keep Huang's return on the table. A report said Huang has discussed a comeback with confidants. Treasury Secretary Scott Bessent said Sunday the board needs to "go outside the company."

Elon Musk added a third question, claiming many supply deals were handshakes with Huang. Nvidia reports Tuesday with an interim chief executive and a new question about who holds its supplier relationships. Nvidia has not responded, and no supplier has backed the claim.

The Signal

The market sold Nvidia's leadership before its numbers. Tuesday's guide can settle revenue. Only the board can settle who runs the company, and six weeks of losses are waiting on both.

Premier Feature

The MarketBeat Analyst Team Just Released Their Top 5 Stocks to Buy Now — Fully Updated for November.

Every stock on this list carries a high consensus rating across Wall Street and has passed our strict criteria:

  • Robust analyst coverage
  • Market cap of $5 billion or more
  • Full bull and bear case built from MarketBeat data and recent news

Today, you can get the complete list absolutely FREE.

👉 Send My Free Report

ENERGY

Oil fell through a weekend of threats, with a surplus already in the data.

Brent traded near $95.15 early Monday, down about 0.7%. WTI was near $88.

A third U.S. aircraft carrier entered the region Sunday, a U.S. official said. Iran's Revolutionary Guard claimed a drone attack on a U.S. radar in Bahrain. Neither Washington nor Bahrain confirmed a hit.

Washington's reported condition for holding fire on Iran met its first test within hours. Trump told advisers he may hold off on an attack if Tehran and the Houthis avoid new provocations, people familiar said. Officials said he had not decided.

The supply math pointed the other way. The International Energy Agency said global supply topped demand in October for the first time since the war began. Observed inventories rose 52 million barrels.

Polymarket's Nov. 30 U.S.-Iran ceasefire contract was near 65 cents, down from 68 early Sunday.

Energy Signal

The weekend's attacks are still unconfirmed. The surplus is already in the inventory data, and oil fell anyway. A confirmed hit in Bahrain would test that trade quickly.

MACRO AND RATES

Japan shrank, and its leading hawk still wants to hike.

Japan's economy contracted at a 0.1% annualized pace in the third quarter, its first contraction in four quarters. Forecasters expected 0.2% growth. Private consumption fell 0.3%, while business investment rose 1.6%.

Bank of Japan board member Hajime Takata said the bank must raise rates "nimbly." He proposed 1.5% in October. The yen sat near 159.6 per dollar.

The two-year Treasury yield rose about 35 basis points last week to near 4.87%, and the 10-year rose about 29 basis points to near 5.14%. Futures price about 90 basis points of tightening by late 2027.

Kalshi's quarter-point December contract has dipped twice in two days, and each time the money told a different story. It sat at 88 cents Monday morning. The bet on a bigger hike slipped to 9 cents from 11.

Fed Chair Kevin Warsh opens a San Francisco Fed conference on AI and productivity Monday.

Macro Signal

A shrinking Japan is still a hiking Japan, and a December hike is now the U.S. base case. Traders mostly agree the next move is a quarter point. The bigger bet is on how long the hikes run.

From Our Partners

Elon Musk is the richest man on earth – now worth an estimated $925 BILLION.

But unlike most people, Elon’s wealth doesn’t come from a salary or a pension…

It comes from something completely different…

And today, legendary investor James Altucher reveals how YOU can follow Elon’s wealth-building blueprint…

In a brand-new FREE report called “Elon’s Trillion Dollar Money Map”.

Click here to learn how to claim your FREE copy of this essential report NOW.

CAPITAL

The AI build-out's private money is waiting for better terms.

Nscale's amended IPO filing says it will need more money for 2027. In September, the British neocloud said it had funding for at least 12 months.

Nine-month revenue rose to $307.5 million from $21.3 million. The net loss grew to $1.69 billion, and debt reached $5.52 billion. Signed contracts run to about $105.8 billion, but Nscale says it has no binding commitments yet for the financing its largest customer deals require.

Nvidia has been the build-out's anchor check. It joined 105 venture rounds this year, PitchBook data show. Investors and founders expect fewer, smaller checks under its interim chief. Nothing Nvidia has said or filed shows a change.

Its compute-financing platform with Apollo, Blackstone, KKR and others, meant to mobilize $500 billion, has produced no deals, a report said. Partners wanted more than Nvidia's offer to backstop up to 25% of residual value.

Capital Signal

Neoclouds grew on borrowed money and Nvidia's name. Now Nscale says it needs more cash, and Nvidia is between chief executives. Lenders will price the next GPU loan on the backstop, not the backlog.

CRYPTO PULSE

Bitcoin's weekend washout reaches Wall Street's crypto stocks today.

Bitcoin fell to around $62,000 on Saturday while ETFs were shut, its weakest since mid-July. About $2 billion of leveraged bets were wiped out in 24 hours, mostly longs.

Strategy (MSTR) traded about 7% lower before the bell, and Coinbase (COIN) about 6% lower. Bitcoin, near $64,500 early Monday, sits about $11,000 below Strategy's average cost of $75,456.

It closed the week near $65,300, its sixth straight weekly loss.

The $60,000 put is now the largest single open position on Deribit, at about $900 million, after bullish bets at $100,000 were cut back. Much of that put position was built over months as protection. The Fear & Greed index sat near 10.

Spot bitcoin funds lost $1.07 billion in the week to Nov. 13, seven straight sessions of outflows. Monday's flows are the first since the weekend low.

The Verdict

Leverage cleared over the weekend. The buyers did not come back with it. Funds sold for seven straight sessions through Friday, the biggest open bet is protection at $60,000, and crypto stocks are only now pricing Saturday.

Partner Spotlight

Middle East Conflict Lights Fuse on US Debt Bomb

America was already drowning in $38 trillion of debt, but the recent conflict in the Middle East just accelerated the timeline.

As oil spikes, a 100-year-old stock market signal that accurately predicted the 2008 and 2020 crashes is flashing a massive "Sell" on dozens of popular U.S. equities.

If you hold the wrong stocks when this debt crisis hits, it could wipe out years of gains.

Click here to see the 10 popular stocks to dump immediately

11780 US Highway 1, Palm Beach Gardens, FL 33408-3080 Would you like to edit your e-mail notification preferences or unsubscribe from our mailing list? Copyright © 2026 Weiss Ratings. All rights reserved.

CLOSING LENS

Some Nvidia investors want the door left open for its founder, and the Treasury Secretary wants an outsider.

Oil fell through a third carrier and an unconfirmed radar strike.

Japan shrank and still talked about hiking.

Nscale needs more money while one of AI's biggest startup backers changes chiefs.

Bitcoin flushed its leverage and kept its sellers.

Warsh speaks Monday, retail sales and Nvidia land Tuesday, and the Fed's minutes follow Wednesday.

This week has plenty of prices and very few buyers.

AI Found the Target. AI Designed the Drug. Now It's in Phase III.

For years, AI drug discovery had a problem. Plenty of models. Very few medicines.
That's changing. One company says AI identified the biological target and then designed the molecule to hit it. In September, the first patient in its Phase III trial was dosed.
It isn't alone. A second AI-engineered medicine is in Phase III, and Big Pharma is now paying for the technology.
We profiled the 5 companies pushing AI into real drug development in a new FREE Special Report: AI Moves Into the Biotech Lab.
We'll text it straight to your phone.

Get the Free Report by Text →